Breaking News Instant updates and real-time market news.

AGN

Allergan

$170.56

-1.73 (-1.00%)

16:33
01/08/18
01/08
16:33
01/08/18
16:33

Allergan sees FY18 adjusted performance EPS at least $15.25, consensus $15.80

Sees FY18 revenue $15B-$15.3B, consensus $15.61B. Commenting on the company's 2018 outlook, Allergan Chairman and CEO Brent Saunders said, "While we face loss of exclusivity revenue headwinds in 2018, Allergan is in a solid position to unlock value in the near- and long-term. Our confidence is driven by the durable growth prospects for our businesses, the efforts we are taking to right-size the organization, our therapeutic area leadership, deep and high-potential pipeline and strong cash flows and balance sheet. Together, these elements provide a formidable foundation for Allergan to deliver value for shareholders in 2018 and beyond."

  • 08

    Jan

  • 06

    Feb

  • 16

    Feb

  • 25

    Mar

AGN Allergan
$170.56

-1.73 (-1.00%)

12/08/17
RHCO
12/08/17
NO CHANGE
Target $53
RHCO
Buy
Revance price target raised to $53 from $32 at SunTrust
SunTrust analyst John Boris raised his price target on Revance (RVNC) to $53, saying the company's RT002's clinical data is "de-risked in glabellar lines", offering significant differentiation relative to Allegan's (AGN) Botox. Boris expects GL SAKURA data to be presented in February of 2018, modeling approval by the first half of 2020. The analyst also notes that the RT0002 Phase-2 plantar fasciitis data on track for December and the initiation of Phase 3 cervical dystonia trials for Q2 of next year, keeping his Buy rating on the stock.
12/19/17
FBCO
12/19/17
NO CHANGE
Target $214
FBCO
Outperform
Allergan price target lowered to $214 from $224 at Credit Suisse
Credit Suisse analyst Vamil Divan price target lowered to $214 from $224 following the company's disappointing performance during the latter part of 2017. The analyst notes that questions around base business and effect of LOEs have impacted stock, but expectations and valuation are now more reasonable. Divan reiterates an Outperform rating on the shares.
01/03/18
LEER
01/03/18
NO CHANGE
LEER
Outperform
Allergan restructuring as expected, risk to guidance low, says Leerink
Leerink analyst Seamus Fernandez says that Allergan's restructuring details announced this morning strongly suggest that the company can and will achieve its 2018 net income guidance. The analyst notes that his discussion with Allergan following today's press release confirmed that its 2018 guidance during the Q3 call did not include the impact of tax reform and that the one referenced in today's press release does not include it either. That said, since Restasis generics have not launched and appears unlikely prior to mid-2018, Fernandez believes the $15 floor guidance likely will be firmly intact with the $300-400M restructuring benefit announced today. The analyst reiterates an Outperform rating on the shares.
01/05/18
WELS
01/05/18
NO CHANGE
Target $245
WELS
Outperform
Allergan has built 'great barrier' around Botox, says Wells Fargo
Wells Fargo analyst David Maris conducted a survey of 25 plastic surgeons and dermatologists to gain insight on the changing neurotoxin landscape. The survey shows Allergan's (AGN) patient and physician loyalty programs and bundling discounts create a "great barrier" around Botox, Maris tells investors in a research note. It is unclear how significant a potential competitor Revance's (RVNC) RT002 could be to Allergan's largest product, the analyst adds. He believes that even with new innovative treatment options, Botox is expected to maintain its dominance in the neurotoxin market. Further, the analyst says that while RT002 showed statistically significant results at week 24 versus placebo, the endpoint doesn't seem not match the FDA's published guidance. Maris wonders if the data will be enough to get a six-month duration claim on the RT002 label, or if Revance is just hoping for an approval and then will point to the duration data. He keeps an Outperform rating on Allergan with a $245 price target.

TODAY'S FREE FLY STORIES

INTU

Intuit

$190.41

-1.33 (-0.69%)

21:46
05/22/18
05/22
21:46
05/22/18
21:46
Downgrade
Intuit rating change at First Analysis »

Intuit downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 12

    Jun

SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

, SPX

S&P 500

$0.00

(0.00%)

21:05
05/22/18
05/22
21:05
05/22/18
21:05
Periodicals
Trump to propose further tax cuts before November, Reuters reports »

President Trump has…

SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$42.26

-1.36 (-3.12%)

20:49
05/22/18
05/22
20:49
05/22/18
20:49
Syndicate
FB Financial 3.2M share Secondary priced at $41.25 »

JPMorgan and Stephens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 24

    Sep

  • 23

    May

MYOK

MyoKardia

$50.45

2.15 (4.45%)

20:48
05/22/18
05/22
20:48
05/22/18
20:48
Syndicate
MyoKardia 3.75M share Secondary priced at $49.00 »

JPMorgan, BofA/Merrill,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

TWOU

2U

$91.64

-3.86 (-4.04%)

20:47
05/22/18
05/22
20:47
05/22/18
20:47
Syndicate
2U 3.3M share Secondary priced at $90.00 »

Goldman Sachs and Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

ARDX

Ardelyx

$4.50

-1.15 (-20.35%)

20:46
05/22/18
05/22
20:46
05/22/18
20:46
Syndicate
Ardelyx 12.5M share Secondary priced at $4.00 »

Jefferies and Leerink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

  • 23

    May

LOW

Lowe's

$85.74

-1.63 (-1.87%)

, TGT

Target

$75.42

-1.44 (-1.87%)

20:25
05/22/18
05/22
20:25
05/22/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

LOW

Lowe's

$85.74

-1.63 (-1.87%)

TGT

Target

$75.42

-1.44 (-1.87%)

TIF

Tiffany

$102.26

-0.96 (-0.93%)

RL

Ralph Lauren

$116.67

-0.41 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 07

    Jun

  • 19

    Jun

  • 26

    Jun

INFO

IHS Markit

$51.28

-0.32 (-0.62%)

20:02
05/22/18
05/22
20:02
05/22/18
20:02
Hot Stocks
IHS Markit expands MarkitSERV trade reporting solution in Asia and Europe »

IHS Markit (INFO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDAY

Ceridian

$34.31

-0.885 (-2.51%)

19:54
05/22/18
05/22
19:54
05/22/18
19:54
Recommendations
Ceridian analyst commentary at MUFG »

Ceridian price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

RMTI

Rockwell Medical

$5.94

-0.06 (-1.00%)

19:20
05/22/18
05/22
19:20
05/22/18
19:20
Hot Stocks
Rockwell Medical president, CEO Chioini terminated from his positions »

Rockwell Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,582.10

-3.45 (-0.22%)

19:16
05/22/18
05/22
19:16
05/22/18
19:16
Periodicals
Amazon.com has banned some shoppers who make excessive returns, WSJ says »

Amazon.com has banned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

CTRP

Ctrip

$43.46

0.48 (1.12%)

, HPE

HP Enterprise

$17.49

-0.01 (-0.06%)

19:03
05/22/18
05/22
19:03
05/22/18
19:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Ctrip…

CTRP

Ctrip

$43.46

0.48 (1.12%)

HPE

HP Enterprise

$17.49

-0.01 (-0.06%)

ARCO

Arcos Dorados

$7.55

0.35 (4.86%)

MET

MetLife

$48.48

0.405 (0.84%)

RRGB

Red Robin

$57.80

-2.9 (-4.78%)

TCS

Container Store

$8.23

0.68 (9.01%)

URBN

Urban Outfitters

$41.21

-1.09 (-2.58%)

CRIS

Curis

$0.53

0.0211 (4.13%)

IBTX

Independent Bank

$77.85

-0.7 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 30

    May

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 10

    Jul

  • 10

    Sep

  • 24

    Sep

EADSY

Airbus

$0.00

(0.00%)

, BA

Boeing

$355.06

-8.89 (-2.44%)

18:59
05/22/18
05/22
18:59
05/22/18
18:59
Periodicals
Airbus says plane subsidies over, U.S. rejects notion, WSJ says »

The U.S. and EU have…

EADSY

Airbus

$0.00

(0.00%)

BA

Boeing

$355.06

-8.89 (-2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

QTNA

Quantenna Communications

$14.94

-0.13 (-0.86%)

18:43
05/22/18
05/22
18:43
05/22/18
18:43
Initiation
Quantenna Communications initiated at William Blair »

Quantenna assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

ALGT

Allegiant Travel

$153.95

-5.15 (-3.24%)

18:42
05/22/18
05/22
18:42
05/22/18
18:42
Hot Stocks
Allegiant Travel announces tentative dispatchers contract agreement with IBT »

Allegiant announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

EA

Electronic Arts

$132.18

-0.73 (-0.55%)

18:30
05/22/18
05/22
18:30
05/22/18
18:30
Recommendations
Electronic Arts analyst commentary at Baird »

Electronic Arts'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$145.96

-3.74 (-2.50%)

18:22
05/22/18
05/22
18:22
05/22/18
18:22
Hot Stocks
Pool Corp. director Stokely sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

  • 13

    Jun

RRGB

Red Robin

$57.80

-2.9 (-4.78%)

18:16
05/22/18
05/22
18:16
05/22/18
18:16
Recommendations
Red Robin analyst commentary at Stephens »

Red Robin Q1 traffic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

BGS

B&G Foods

$26.50

-0.75 (-2.75%)

18:11
05/22/18
05/22
18:11
05/22/18
18:11
Hot Stocks
B&G Foods increases dividend 2.2% to 47.5c »

B&G Foods announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

CTRP

Ctrip

$43.46

0.48 (1.12%)

18:05
05/22/18
05/22
18:05
05/22/18
18:05
Hot Stocks
Breaking Hot Stocks news story on Ctrip »

Ctrip falls over 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

CTRP

Ctrip

$43.46

0.48 (1.12%)

18:05
05/22/18
05/22
18:05
05/22/18
18:05
Earnings
Ctrip reports Q1 adjusted earnings per ADS 55c, may not compare to consensus 16c »

Reports Q1 revenue $1.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

PLBC

Plumas Bancorp

$28.00

(0.00%)

18:02
05/22/18
05/22
18:02
05/22/18
18:02
Hot Stocks
Plumas Bank agrees to purchase Carson City branch of Mutual of Omaha Bank »

Plumas Bank, the wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip

$43.46

0.48 (1.12%)

18:02
05/22/18
05/22
18:02
05/22/18
18:02
Earnings
Breaking Earnings news story on Ctrip »

Ctrip sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

CRIS

Curis

$0.53

0.0211 (4.13%)

17:56
05/22/18
05/22
17:56
05/22/18
17:56
Hot Stocks
Curis announces 1-for-5 reverse stock split »

Curis announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCS

Container Store

$8.23

0.68 (9.01%)

17:47
05/22/18
05/22
17:47
05/22/18
17:47
Hot Stocks
Container Store drops 12% after Q4 EPS lower than estimates »

Shares of the Container…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.